Submission Details
| 510(k) Number | K254033 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 16, 2025 |
| Decision Date | February 09, 2026 |
| Days to Decision | 55 days |
| Submission Type | Abbreviated |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K254033 is an FDA 510(k) clearance for the Ceribell Instant EEG Headset, a Electrode, Cutaneous (Class II — Special Controls, product code GXY), submitted by Ceribell, Inc. (Sunnyvale, US). The FDA issued a Cleared decision on February 9, 2026, 55 days after receiving the submission on December 16, 2025. This device falls under the Neurology review panel. Regulated under 21 CFR 882.1320.
| 510(k) Number | K254033 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 16, 2025 |
| Decision Date | February 09, 2026 |
| Days to Decision | 55 days |
| Submission Type | Abbreviated |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | GXY — Electrode, Cutaneous |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.1320 |